Feed & Additive Magazine Issue 47 December 2024

NEWS FEED & ADDITIVE MAGAZINE December 2024 103 One of the global market leaders in chemicals and ingredients distribution, Brenntag announced a new and exclusive distribution agreement between Brenntag Animal Nutrition, producer and provider of solutions and ingredients to the feed and pet food producers, with BTSA for the distribution of Oxabiol, natural antioxidants, for the animal nutrition industry in Europe. BTSA is a European manufacturer of antioxidants for many industries including food, animal nutrition and cosmetics. This new agreement is reportedly an important next step in the collaboration between the two companies that has already started in 2019. Wouter Vullings, Director Animal Nutrition EMEA, states: “We are looking forward to expanding our long-year collaboration into an exclusive cooperation. BTSA's antioxidants complement Brenntag's Animal Nutrition portfolio by completing the existing portfolio of traditional antioxidants synergistic portfolio. This agreement supports our long-term strategic goal to expand our presence as a leading ingredients supplier in the Animal Nutrition and Pet Food industry in the EMEA region." The agreement includes natural antioxidants - also available in an organic version - for animal feed, pet food and rendering products based on tocopherol blends and synergistic combinations with rosemary extract, green tea extract and others. Antioxidants are an essential component in the pet food, rendering and animal nutrition industries. They help extend shelflife, protect nutrients and improve overall quality and palatability of the products by minimizing spoilage produced by oxidation. Read more>> One of the largest animal health global players, present in 110 countries, Ceva Animal Health unveiled its latest investment in European vaccine manufacturing, with the construction of a new facility in Hungary, expanding the capacity of Ceva Phylaxia. The company pointed out that Ceva Phylaxia, with over a century of expertise, has been at the forefront of combating major livestock diseases through innovative research and vaccine development. This development will establish a 7,000 m2 plant in Monor, Hungary with the most advanced technologies, where Ceva will produce fermentation-based multicomponent inactivated vaccines for animals. “Building a new facility is always a significant milestone in the life of a company. In Hungary, we already benefit from a strong historical expertise with our Ceva Phylaxia campus. With the addition of this new production unit in Monor, we aim to create new synergies to advance preventive medicine. This project reflects our commitment to supporting farmers worldwide by developing tailored solutions to tackle emerging diseases and new variants. It embodies our ambition to build a promising future for our company, employees, and partners, both in Hungary and internationally, while strengthening our research and development capabilities,” said Marc Prikazsky, Chairman and CEO of Ceva Animal Health. Read more>> Brenntag Animal Nutrition makes exclusive distribution agreement for Europe Ceva invests in new animal vaccine manufacturing plant

RkJQdWJsaXNoZXIy MTUxNjkxNQ==